|
2024
|
P/S
|
Preparations for treatment of human diseases of the autonomic, circulatory, and central nervous s... |
|
|
Invention
|
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds.
The invention relates to compounds of f... |
|
|
Invention
|
Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyiso... |
|
2023
|
Invention
|
Pyrimidine compound as jak kinase inhibitor. The invention provides a compound of formula (I):
... |
|
|
Invention
|
Naphthyridine compounds as jak kinase inhibitors.
The invention provides compounds of formula (I... |
|
|
Invention
|
Crystalline hydrate of a jak inhibitor compound. Provided herein is a crystalline hydrate of the ... |
|
|
Invention
|
Process for preparing jak inhibitors and intermediates thereof. The present disclosure relates ge... |
|
|
Invention
|
Crystalline freebase forms of a biphenyl compound. The invention provides two crystalline freebas... |
|
|
P/S
|
Pharmaceuticals, namely, medical and veterinary pharmaceutical preparations for the treatment of ... |
|
|
Invention
|
Nezulcitinib for delivery by nebulized oral inhalation. Provided herein is a method of treating a... |
|
|
Invention
|
Substituted pyrimidines and methods of use.
The present disclosure provides inhibitors of activi... |
|
|
Invention
|
Methods for treating chronic obstructive pulmonary disease.
Methods for treating chronic obstruc... |
|
|
Invention
|
Methods for treating chronic obstructive pulmonary disease. 1 and trough forced vital capacity (F... |
|
|
Invention
|
Methods for treating a subject having multiple system atrophy.
Disclosed are methods for treatin... |
|
|
Invention
|
Ampreloxetine for use for treating multiple system atrophy. Disclosed are methods for treating a ... |
|
|
Invention
|
Dimethyl amino azetidine amides as jak inhibitors.
The invention provides compounds of formula (... |
|
|
Invention
|
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound.
The invention prov... |
|
|
Invention
|
Neprilysin inhibitors. In one aspect, the invention relates to compounds having the formula:
7 a... |
|
|
Invention
|
Substituted pyridines and methods of use.
The present disclosure provides inhibitors of activin ... |
|
2022
|
Invention
|
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists.
The invention provides no... |
|
|
Invention
|
Neprilysin inhibitors. In one aspect, the invention relates to compounds having the formula:
6, ... |
|
|
Invention
|
Bicyclic inhibitors of jak and methods of use. The present disclosure provides inhibitors of the ... |
|
|
Invention
|
Jak inhibitors containing a 4-membered heterocyclic amide. The invention provides compounds of fo... |
|
|
Invention
|
Imidazolo indazole compounds as jak inhibitors.
Provided herein are compounds of formula (I):
... |
|
|
Invention
|
Imidazolo indazole compounds as jak inhibitors. Provided herein are compounds of formula (I): (I)... |
|
|
Invention
|
Method of treating a patient infected with a coronavirus and having a baseline level of crp below... |
|
|
Invention
|
Crystalline forms of a biphenyl compound.
The invention provides crystalline forms of biphenyl-2... |
|
|
Invention
|
Bicyclic inhibitors of alk5 and methods of use. The present disclosure provides inhibitors of act... |
|
|
Invention
|
Enantioselective synthesis of aminotropane compound. The present disclosure provides processes fo... |
|
|
Invention
|
Crystalline form of a dihydrochloride salt of a jak inhibitor compound. Provided herein is a crys... |
|
|
Invention
|
Crystalline form of a dihydrochloride salt of a jak inhibitor compound.
Provided herein is a cry... |
|
|
Invention
|
Crystalline form of a dihydrochloride salt of a jak inhibitor compound. HHH-indazol-6-yl)phenol. ... |
|
|
Invention
|
Jak kinase inhibitor compounds for treatment of respiratory disease. The invention provides compo... |
|
|
Invention
|
Amino amide tetrahydro imidazo pyridines as jak inhibitors. Provided herein are compounds of form... |
|
|
Invention
|
Fused imidazo-piperidine jak inhibitors. The invention provides compounds of formula (I):
where... |
|
|
Invention
|
Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists.
The invention relates to benzimi... |
|
|
Invention
|
Biphenyl compounds useful as muscarinic receptor antagonists.
This invention provides compounds ... |
|
2021
|
Invention
|
Crystalline (2s,4r)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyiso... |
|
|
Invention
|
Synthesis of 5, 7-dichloro-1, 6-naphthyridine. The present disclosure provides processes for prep... |
|
|
Invention
|
Formulation of a pan-jak inhibitor. The present disclosure relates to pharmaceutical compositions... |
|
|
Invention
|
Processes for preparing a pan-jak inhibitor and related intermediate compounds. RsSS)-3-((7-((5-m... |
|
|
Invention
|
Formulation of a pan-jak inhibitor. RsSS)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridi... |
|
|
Invention
|
Substituted pyrimidines and methods of use. The present disclosure provides inhibitors of activin... |
|
|
Invention
|
Pyrazolo and triazolo bicyclic compounds as jak kinase inhibitors.
The invention provides compou... |
|
|
Invention
|
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds. The invention relates to compounds of fo... |
|
2015
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of respiratory diseases and disorde... |
|
2014
|
P/S
|
Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders |
|
2011
|
P/S
|
Pharmaceuticals for the treatment of human diseases of the respiratory system and as anti-infecti... |
|
|
P/S
|
Pharmaceutical research and development; Research and development in the field of pharmaceuticals... |
|
2005
|
P/S
|
Full line of pharmaceuticals. |
|
2003
|
P/S
|
Pharmaceutical preparations; a full line of pharmaceutical preparations and pharmaceutically-acti... |
|
2002
|
P/S
|
Pharmaceutical preparations, namely anti-infectives. |
|
2001
|
P/S
|
Pharmaceutical preparations. |
